Literature DB >> 23992543

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus.

Ana Maria Arbelaez1, Dongyuan Xing, Philip E Cryer, Craig Kollman, Roy W Beck, Jennifer Sherr, Katrina J Ruedy, William V Tamborlane, Nelly Mauras, Eva Tsalikian, Darrell M Wilson, Neil H White.   

Abstract

CONTEXT: Glycemic control is limited by the barrier of hypoglycemia. Recurrent hypoglycemia impairs counterregulatory (CR) hormone responses to subsequent hypoglycemia.
OBJECTIVE: To determine the glucagon and epinephrine responses to insulin-induced hypoglycemia in adolescents with recent-onset type 1 diabetes mellitus (T1DM).
METHODS: We assessed the CR responses to hypoglycemia by performing a hyperinsulinemic (2.0 mU/kg/min), euglycemic (BG 90 mg/dL; 5.0 mmol/L)-hypoglycemic (BG 55 mg/dL; 3.0 mmol/L) clamp in 25 recent-onset (<1 yr duration) patients 9-18 yr old (mean ± SD: 13.4 ± 2.7) with T1DM and 16 non-diabetic controls 19-25 yr old (mean ± SD 23.3 ± 1.8). Twenty of the T1DM subjects were retested 1-yr (53 ± 3 wk) later.
RESULTS: At the initial and 1-yr studies, peak glucagon (pGON) and incremental glucagon (ΔGON) during hypoglycemia were lower in the T1DM subjects [median pGON = 47 pg/mL (quartiles: 34, 72), ΔGON = 16 (4, 27) initially and pGON = 50 pg/mL (42, 70), ΔGON = 12 (9, 19) at 1-yr] than in controls [pGON = 93 pg/mL (60, 111); ΔGON = 38 pg/mL (19, 66), p = 0.01 and p = 0.004 for ΔGON at initial and 1-yr study, respectively]. In contrast, peak epinephrine (pEPI) and incremental epinephrine (ΔEPI) levels were similar in the T1DM (pEPI = 356 pg/mL (174, 797) and ΔEPI = 322 pg/mL (143, 781) initially and pEPI = 469 pg/mL (305, 595) and ΔEPI = 440 pg/mL (285, 574) at 1 yr) and in controls (pEPI = 383 pg/mL (329, 493) and ΔEPI = 336 pg/mL (298, 471) p = 0.97 and 0.21 for ΔEPI at initial and 1-yr study, respectively).
CONCLUSIONS: Even within the first year of T1DM, glucagon responses to hypoglycemia are blunted but epinephrine responses are not, suggesting that the mechanisms involved in the loss of these hormonal responses, which are key components in pathophysiology of hypoglycemia-associated autonomic failure, are different.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  children; counterregulation; epinephrine; glucagon; hypoglycemia; type 1 diabetes mellitus

Mesh:

Substances:

Year:  2013        PMID: 23992543      PMCID: PMC3858506          DOI: 10.1111/pedi.12070

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  18 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.

Authors:  L A Donnelly; A D Morris; B M Frier; J D Ellis; P T Donnan; R Durrant; M M Band; G Reekie; G P Leese
Journal:  Diabet Med       Date:  2005-06       Impact factor: 4.359

3.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM).

Authors:  R P Hoffman; C Singer-Granick; A L Drash; D J Becker
Journal:  J Pediatr Endocrinol       Date:  1994 Jul-Sep

5.  Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.

Authors:  G Bolli; P de Feo; P Compagnucci; M G Cartechini; G Angeletti; F Santeusanio; P Brunetti; J E Gerich
Journal:  Diabetes       Date:  1983-02       Impact factor: 9.461

6.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

7.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

8.  Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes.

Authors:  Aris Siafarikas; Robert J Johnston; Max K Bulsara; Peter O'Leary; Timothy W Jones; Elizabeth A Davis
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

9.  Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.

Authors:  Jennifer Sherr; Dongyuan Xing; Katrina J Ruedy; Roy W Beck; Craig Kollman; Bruce Buckingham; Neil H White; Larry Fox; Eva Tsalikian; Stuart Weinzimer; Ana Maria Arbelaez; William V Tamborlane
Journal:  Diabetes Care       Date:  2013-01-03       Impact factor: 19.112

Review 10.  The barrier of hypoglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Diabetes       Date:  2008-12       Impact factor: 9.461

View more
  21 in total

1.  Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes?

Authors:  Lournaris Torres-Santiago; Nelly Mauras; Jobayer Hossain; Arthur L Weltman; Dominique Darmaun
Journal:  Nutrition       Date:  2016-09-20       Impact factor: 4.008

2.  Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.

Authors:  Sabrina Lyngbye Wendt; Ajenthen Ranjan; Jan Kloppenborg Møller; Signe Schmidt; Carsten Boye Knudsen; Jens Juul Holst; Sten Madsbad; Henrik Madsen; Kirsten Nørgaard; John Bagterp Jørgensen
Journal:  J Diabetes Sci Technol       Date:  2017-02-01

Review 3.  Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology.

Authors:  Paola Lucidi; Francesca Porcellati; Geremia B Bolli; Carmine G Fanelli
Journal:  Curr Diab Rep       Date:  2018-08-18       Impact factor: 4.810

4.  The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.

Authors:  Siri Fredheim; Marie-Louise M Andersen; Sven Pörksen; Lotte B Nielsen; Christian Pipper; Lars Hansen; Jens J Holst; Jane Thomsen; Jesper Johannesen; Henrik B Mortensen; Jannet Svensson
Journal:  Diabetologia       Date:  2014-12-27       Impact factor: 10.122

5.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

Review 6.  Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.

Authors:  Thomas O Mundinger; Gerald J Taborsky
Journal:  Diabetologia       Date:  2016-06-24       Impact factor: 10.122

Review 7.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

8.  High residual C-peptide likely contributes to glycemic control in type 1 diabetes.

Authors:  Michael R Rickels; Carmella Evans-Molina; Henry T Bahnson; Alyssa Ylescupidez; Kristen J Nadeau; Wei Hao; Mark A Clements; Jennifer L Sherr; Richard E Pratley; Tamara S Hannon; Viral N Shah; Kellee M Miller; Carla J Greenbaum
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 9.  Management of Hypoglycemia in Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Dayna E McGill; Lynne L Levitsky
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

10.  Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.

Authors:  Erwan Leclair; Richard T Liggins; Ashley J Peckett; Trevor Teich; David H Coy; Mladen Vranic; Michael C Riddell
Journal:  Diabetologia       Date:  2016-04-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.